- Home
- CVR vs ALLR Comparison
CVR vs ALLR Comparison
Compare CVR & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVR
- ALLR
- Stock Information
- Founded
- CVR 1920
- ALLR 2004
- Country
- CVR United States
- ALLR United States
- Employees
- CVR N/A
- ALLR N/A
- Industry
- CVR Industrial Machinery/Components
- ALLR Biotechnology: Pharmaceutical Preparations
- Sector
- CVR Industrials
- ALLR Health Care
- Exchange
- CVR Nasdaq
- ALLR Nasdaq
- Market Cap
- CVR 11.1M
- ALLR 13.3M
- IPO Year
- CVR N/A
- ALLR N/A
- Fundamental
- Price
- CVR $12.00
- ALLR $0.90
- Analyst Decision
- CVR
- ALLR
- Analyst Count
- CVR 0
- ALLR 0
- Target Price
- CVR N/A
- ALLR N/A
- AVG Volume (30 Days)
- CVR 2.5K
- ALLR 453.6K
- Earning Date
- CVR 08-12-2025
- ALLR 08-04-2025
- Dividend Yield
- CVR 1.04%
- ALLR N/A
- EPS Growth
- CVR N/A
- ALLR N/A
- EPS
- CVR N/A
- ALLR N/A
- Revenue
- CVR $26,379,081.00
- ALLR N/A
- Revenue This Year
- CVR N/A
- ALLR N/A
- Revenue Next Year
- CVR N/A
- ALLR N/A
- P/E Ratio
- CVR N/A
- ALLR N/A
- Revenue Growth
- CVR N/A
- ALLR N/A
- 52 Week Low
- CVR $8.15
- ALLR $0.61
- 52 Week High
- CVR $22.27
- ALLR $14.25
- Technical
- Relative Strength Index (RSI)
- CVR 38.45
- ALLR 49.46
- Support Level
- CVR $13.20
- ALLR $0.80
- Resistance Level
- CVR $13.86
- ALLR $0.98
- Average True Range (ATR)
- CVR 0.79
- ALLR 0.06
- MACD
- CVR -0.26
- ALLR 0.01
- Stochastic Oscillator
- CVR 0.00
- ALLR 61.93
About CVR Chicago Rivet & Machine Co.
Chicago Rivet & Machine Co is in the fastener industry in North America. The company operates in two segments namely fasteners and assembly equipment. Its fastener segment consists of the manufacture and sale of rivets, cold-formed fasteners, parts, and screw machine products. The assembly equipment segment consists mainly of the manufacture of automatic rivet setting machines, automatic assembly equipment, and parts and tools for such machines. The majority of revenue is from the fastener segment.
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.